Thus, we speculate that in IBD, the migration of IL-26-producing PBMCs into the inflamed intestine may result in reduced expression of IL-26 mRNA in PBMCs and elevated expression of IL-26 in the inflamed intestinal mucosa. The gene discussed is IL26; the disease is inflammatory bowel disease.